We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Coagulation Test Correlates Protein Concentration for Plasma Cell Dyscrasia

By LabMedica International staff writers
Posted on 07 Jan 2013
Abnormal screening coagulation tests are frequently observed in asymptomatic patients with multiple myeloma and other plasma cell neoplasms. More...


Prothrombin time (PT), activated partial thromboplastin time (APTT) and fibrinogen activity have been linked with clinical history and disease parameters in patients with plasma cell dyscrasia.

Scientists at the University of Arkansas for Medical Sciences (Little Rock, AR, USA) studied coagulation tests in a total of 252 patients. Of these, 79 patients (31%) had abnormal routine screening coagulation test results. An isolated prolonged PT of greater than 15 seconds was found in 62 patients (25%), and 10 patients had prolonged PT and APTT (4%).

Prothrombin time, APTT, and fibrinogen activity were analyzed on the STA-R Evolution, using PT reagent Neoplastine CI PLUS and APTT reagent STA-PTT A, all products of Diagnostica Stago (Parsippany, NJ, USA). Fibrinogen activity was determined by measuring the clotting time of diluted plasma in the presence of excess thrombin with a reference range of 197–447 mg/dL. The quantitation of monoclonal proteins was performed by separating serum proteins using capillary electrophoresis with direct protein detection by UV absorbance at 200 nm.

An isolated prolonged PT was the most common abnormal coagulation test found in 25% of the patients. A prolonged PT was more frequently observed in 157patients with the multiple myeloma compared to the 34 monoclonal gammopathy of undetermined significance (MGUS) patients or other diagnostic categories of plasma cell dyscrasia. There were no differences immunoglobulin isotype in 62 patients with isolated prolonged PT compared to the 173 patients with normal screening coagulation tests. Fibrinogen activity was significantly lower in patients with prolonged PT although there was no correlation between fibrinogen activity and PT. Serum M protein concentrations were significantly greater in patients with prolonged PT and were positively correlated with PT. Serum M protein concentrations were significantly elevated in patients with prolonged PT compared to patients with normal PT and were positively correlated with PT values.

The authors concluded that there was an association between disease severity and prolonged PT in that patients with multiple myeloma were more likely to have prolonged PT than patients with other plasma cell neoplasms. Of the factors examined, the monoclonal protein level was significantly higher in patients with isolated prolonged PT and correlated with PT. The study was published on December 7, 2012, in the International Journal of Laboratory Hematology.

Related Links:
University of Arkansas for Medical Sciences
Diagnostica Stago


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NeoGenomics selected Indica Labs’ HALO AP platform to eable its digital pathology operations through a scalable, cloud-based framework (Photo courtesy of Indica Labs)

Expanded Partnership Scales AI-Powered Digital Pathology for Oncology

Oncology diagnostics rely on pathology and biomarker information to guide personalized treatment. As computational pathology and artificial intelligence (AI) expand insights from tissue analysis, laboratories... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.